All In MedTech

FDA Clearance Tracker · P100006-S008

AUGMENT Injectable

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 11, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 11, 2019

Approved

Time to decision

231 days

Received Oct 23, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100006-S008
Device name
AUGMENT Injectable
Applicant location
Franklin, TN
Received
Oct 23, 2018
Decided
Jun 11, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P100006

Device type

Device class
Class III

Every decision under product code NOX

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Biomimetic Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.